Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Broocks

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Psychological Medicine|July 21, 2004
Smooth pursuit deficits in schizophrenia, affective disorder and obsessive-compulsive disorderR Lencer, P Trillenberg, K Trillenberg-Krecker, et al.
Pharmacopsychiatry|November 9, 2000
The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trialB Bandelow, A Broocks, G Pekrun, et al.
Physiology & Behavior|May 1, 1990
Endocrine findings in restrained eatersK M Pirke, R J Tuschl, B Spyra, et al.
Fertility and Sterility|February 1, 1989
Dieting causes menstrual irregularities in normal weight young women through impairment of episodic luteinizing hormone secretionK M Pirke, U Schweiger, T Strowitzki, et al.
Journal of Neuroimmunology|February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Neurology|December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapseP Rieckmann, S Martin, I Weichselbraun, et al.
Pharmacopsychiatry|June 29, 2011
Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controlsM Sommer, M Braumann, T Althoff, et al.
Biological Psychiatry|April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controlsA Broocks, J T Little, A Martin, et al.
Psychopharmacology|March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatmentA Broocks, N C Briggs, T A Pigott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runnersA Broocks, T Meyer, A George, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Psychological Medicine|July 21, 2004
Smooth pursuit deficits in schizophrenia, affective disorder and obsessive-compulsive disorderR Lencer, P Trillenberg, K Trillenberg-Krecker, et al.
Pharmacopsychiatry|November 9, 2000
The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trialB Bandelow, A Broocks, G Pekrun, et al.
Physiology & Behavior|May 1, 1990
Endocrine findings in restrained eatersK M Pirke, R J Tuschl, B Spyra, et al.
Fertility and Sterility|February 1, 1989
Dieting causes menstrual irregularities in normal weight young women through impairment of episodic luteinizing hormone secretionK M Pirke, U Schweiger, T Strowitzki, et al.
Journal of Neuroimmunology|February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Neurology|December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapseP Rieckmann, S Martin, I Weichselbraun, et al.
Pharmacopsychiatry|June 29, 2011
Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controlsM Sommer, M Braumann, T Althoff, et al.
Biological Psychiatry|April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controlsA Broocks, J T Little, A Martin, et al.
Psychopharmacology|March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatmentA Broocks, N C Briggs, T A Pigott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runnersA Broocks, T Meyer, A George, et al.
Pageof 6